Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fliser

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Kidney International|April 1, 1997
Renal function in the elderly: impact of hypertension and cardiac functionD Fliser, E Franek, M Joest, et al.
American Journal of Hypertension|April 1, 1993
Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockadeD Fliser, R Nowack, N Allendorf-Ostwald, et al.
Clinical Nephrology|September 17, 2008
A hibernating kidney - ischemic preconditioning in a renal transplant recipient with a proximal stenosis of the iliac arteryJ Warncke, S David, P Kümpers, et al.
Contemporary Clinical Trials|July 19, 2011
The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney diseaseD Fliser, F Dellanna, M Koch, et al.
The Proceedings of the Nutrition Society|July 1, 1997
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR)E Ferrannini, S Camastra, S W Coppack, et al.
European Journal of Clinical Pharmacology|June 24, 1999
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchangedD Fliser, I Bischoff, A Hanses, et al.
Clinical Nephrology|June 25, 2002
High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxicationJ T Kielstein, A Schwarz, A Arnavaz, et al.
Journal of Hypertension|March 1, 1997
Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onsetD Fliser, C Keller, P Bahrmann, et al.
Kidney International|February 13, 1999
Coadministration of albumin and furosemide in patients with the nephrotic syndromeD Fliser, I Zurbrüggen, E Mutschler, et al.
International Journal of Clinical Practice|November 25, 2010
Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL studyF Dellanna, R E Winkler, F Bozkurt, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Kidney International|April 1, 1997
Renal function in the elderly: impact of hypertension and cardiac functionD Fliser, E Franek, M Joest, et al.
American Journal of Hypertension|April 1, 1993
Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockadeD Fliser, R Nowack, N Allendorf-Ostwald, et al.
Clinical Nephrology|September 17, 2008
A hibernating kidney - ischemic preconditioning in a renal transplant recipient with a proximal stenosis of the iliac arteryJ Warncke, S David, P Kümpers, et al.
Contemporary Clinical Trials|July 19, 2011
The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney diseaseD Fliser, F Dellanna, M Koch, et al.
The Proceedings of the Nutrition Society|July 1, 1997
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR)E Ferrannini, S Camastra, S W Coppack, et al.
European Journal of Clinical Pharmacology|June 24, 1999
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchangedD Fliser, I Bischoff, A Hanses, et al.
Clinical Nephrology|June 25, 2002
High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxicationJ T Kielstein, A Schwarz, A Arnavaz, et al.
Journal of Hypertension|March 1, 1997
Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onsetD Fliser, C Keller, P Bahrmann, et al.
Kidney International|February 13, 1999
Coadministration of albumin and furosemide in patients with the nephrotic syndromeD Fliser, I Zurbrüggen, E Mutschler, et al.
International Journal of Clinical Practice|November 25, 2010
Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL studyF Dellanna, R E Winkler, F Bozkurt, et al.
Pageof 10